What happens if you take some of the most popular peptides in the space, and put them all in one single vial?

The KLOW blend (GHK-Cu + BPC-157 + TB-500 + KPV), explained: (1/14) KLOW is just the standard GLOW blend with one extra peptide called KPV.

The core GLOW blend is a combination of three peptides that are focused on structural repair:

- BPC-157
- TB-500
- GHK-Cu

Let's get into the role of each one:

Botox is outdated.

Science has discovered that pairing a specific peptide with red light therapy can reverse aging by repairing skin from both outside and inside.

Let's look at the results: (1/10)
Researchers exposed human fibroblasts to red LED light (625–635 nm) at three energy doses, then compared them to fibroblasts that got no light.

On its own, the light maintained cell viability and modestly increased collagen production.

It also did not damage the cells.

Everyone's heard of the famous Wolverine Stack (BPC-157 + TB-500),

But not many really understand how it functions.

Here’s a breakdown of one of the most comprehensive recovery protocols in peptide research: (1/11) To grasp why this stack is effective, you need to know what each peptide does individually.

Both are healing peptides and have anti-inflammatory properties.

But they work in completely different ways, and that's exactly why they pair so well.

Let’s start with BPC-157.

Everyone calls retatrutide "the Ozempic and tirzepatide killer" with triple agonist power.

But if you look at the data we have right now, tirzepatide might be the smarter choice.

Tirzepatide, explained: (1/13) Reta's most cited number is the 24.2% weight loss, from a Phase 2 trial of just 338 people over 48 weeks.

It now has one Phase 3 result (TRIUMPH-4: 28.7%), but that was 445 knee osteoarthritis patients, not a general obesity population.

Tirze's 22.5% came from 2,500+ people.

Retatrutide is positioned to be the best-selling drug ever.

In trials, it led to 24% weight loss over 48 weeks and reversed fatty liver in 93% of patients. Eli Lilly is still working through Phase 3.

But what makes it better than semaglutide and tirzepatide? (1/12) We are seeing three generations of GLP-1 drugs.

- Semaglutide (Ozempic) targets one receptor
- Tirzepatide (Mounjaro) targets two
- Retatrutide hits three

Every new version has essentially doubled the weight loss results of the previous one.

Semax, explained: (1/9) Since 2011, Semax has been on the Russian list of essential drugs. If you have a stroke in Moscow, they put this up your nose in the ambulance.

It's a frontline neuroprotective tool and a standard part of their medical care, not some niche biohack.

Every weight loss drug does one thing: make you eat less.

Retatrutide does that, and makes you burn more calories at rest. No drug has ever done both.

- 86% liver fat reduction
- 72% prediabetes reversal
- 41% stopped needing BP meds

What makes reta different? (1/10)

https://twitter.com/powerbottomdad1/status/2038394751754363332

Retatrutide targets three receptors:

- GLP-1 (appetite)
- GIP (appetite and nausea)
- Glucagon (energy use)

The addition of glucagon is the focus here because it speeds up your metabolic rate.